Search Results

PF-3845 50mg 50mg  | Purity Not Available

Adooq Bioscience

PF-3845 is a potent, selective, and irreversible inhibitor of FAAH (Ki = 0.23 μM). It reduces inflammatory pain via a cannabinoid receptor-dependent mechanism.

More Information Supplier Page

PF-3845 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

PF-3845 is a potent, selective, and irreversible inhibitor of FAAH (Ki = 0.23 μM). It reduces inflammatory pain via a cannabinoid receptor-dependent mechanism.

More Information Supplier Page

PF-3845 100mg 100mg  | Purity Not Available

Adooq Bioscience

PF-3845 is a potent, selective, and irreversible inhibitor of FAAH (Ki = 0.23 μM). It reduces inflammatory pain via a cannabinoid receptor-dependent mechanism.

More Information Supplier Page

PF-3845 10mg 10mg  | Purity Not Available

Adooq Bioscience

PF-3845 is a potent, selective, and irreversible inhibitor of FAAH (Ki = 0.23 μM). It reduces inflammatory pain via a cannabinoid receptor-dependent mechanism.

More Information Supplier Page

WAY-100635 50mg 50mg  | Purity Not Available

Adooq Bioscience

WAY-100635 was originally believed to act as a selective 5-HT1A receptor antagonist, but subsequent research showed that it also acts as potent full agonist at the D4 receptor.

More Information Supplier Page

WAY-100635 100mg 100mg  | Purity Not Available

Adooq Bioscience

WAY-100635 was originally believed to act as a selective 5-HT1A receptor antagonist, but subsequent research showed that it also acts as potent full agonist at the D4 receptor.

More Information Supplier Page

WAY-100635 10mg 10mg  | Purity Not Available

Adooq Bioscience

WAY-100635 was originally believed to act as a selective 5-HT1A receptor antagonist, but subsequent research showed that it also acts as potent full agonist at the D4 receptor.

More Information Supplier Page